The conventional skincare supply chain operates on a manufacture-to-warehouse model. Products are compounded in large batches, shipped to distributors, stored in warehouses, sent to retailers, and eventually purchased by the consumer — a process that takes 6-18 months. During this period, active ingredients degrade continuously, regardless of packaging quality.
The freshness window — the period during which a formulation maintains >90% of its labelled active concentration — is the true measure of a product's efficacy window. For most antioxidant and peptide formulations, this window is approximately 6 months from compounding date when stored at 20°C in sealed, opaque, oxygen-barrier packaging. After 12 months, many actives fall below 70% of their initial concentration.
Made-to-order (MTO) manufacturing inverts this model. The product is compounded after the order is placed, filled within 24-48 hours, and shipped directly to the consumer. The entire 6-month freshness window is spent in the user's possession under their temperature and storage conditions — not in a warehouse at 30°C.
The MTO model is common in other industries with stability-sensitive products — specialty coffee is roasted to order, craft beer is bottled fresh, prescription pharmaceuticals are compounded on demand. Skincare is the outlier in expecting 2-3 year shelf lives from biologically active formulations. The difference is that most skincare brands optimise for retail distribution, not for the user's results.
MTO requires a fundamentally different production system: small-batch compounding equipment, rapid quality control protocols, and a logistics network that prioritises speed over consolidation. The operational complexity is higher, but the user gets a product that performs as the formulator intended, not as the warehouse delivered.